Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,327 public trials 2,839 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

NCT07227311

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Los Alamitos, California, United States
  • GSK Investigational Site Torrance, California, United States
  • GSK Investigational Site Whittier, California, United States
  • GSK Investigational Site Fort Myers, Florida, United States
View all 51 locations
View Trial Details
Recruiting

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

NCT07354074

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University Medical Center New York Presbyterian New York, United States
  • Seattle Childrens Hospital Seattle, Washington, United States
  • Novartis Investigative Site Brisbane, Queensland, Australia
View all 24 locations
View Trial Details
Recruiting

A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06449651

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +5 more
Locations
  • Universitair Ziekenhuis Leuven Leuven, Belgium
  • Instituto de Medicina Integral Professor Fernando Figueira Recife, Brazil
  • Instituto D Or de Pesquisa e Ensino IDOR Rio de Janeiro, Brazil
  • Hospital Das Clinicas Da Faculdade De Medicina Da USP São Paulo, Brazil
View all 21 locations
View Trial Details
Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
Locations
  • Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
  • University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
  • Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
View all 121 locations
View Trial Details

Related conditions